Urology Department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
BMC Urol. 2024 May 16;24(1):107. doi: 10.1186/s12894-024-01496-7.
The aggressive nature of Fournier gangrene and the associated health issues can result in a more complex clinical course and potentially a longer hospital stay. This study aimed to assess factors that affect the length of hospital stay (LHS) and its relation to the outcome of Fournier gangrene patients.
A retrospective study was performed at King Abdulaziz University Hospital (KAUH), Saudi Arabia, on patients diagnosed with Fournier gangrene between 2017 and 2023. Data about length of hospital stay (LHS), age, BMI, clinical and surgical data and outcome was obtained.
The mean age of the studied patients was 59.23 ± 11.19 years, the mean body mass index (BMI) was 26.69 ± 7.99 kg/m and the mean duration of symptoms was 10.27 ± 9.16 days. The most common presenting symptoms were swelling or induration (64%), 88% had comorbidities with diabetes mellitus (DM) (84%), and 76% had uncontrolled DM. of patients, 24% had a poly-microbial infection, with E. coli being the most common (52%). The mean length of hospital stay (LHS) was 54.56 ± 54.57 days, and 24% of patients had an LHS of more than 50 days. Longer LHS (> 50 days) was associated with patients who did not receive a compatible initial antibiotic, whereas shorter LHS was associated with patients who received Impenem or a combination of vancomycin and meropenem as alternative antibiotics following incompatibility. Reconstruction patients had significantly longer LHS and a higher mean temperature. However, none of the studied variables were found to be predictors of long LHS in the multivariate regression analysis.
Knowledge of the values that predict LHS allows for patient-centered treatment and may be useful in predicting more radical treatments or the need for additional treatment in high-risk patients. Future multicenter prospective studies with larger sample sizes are needed to assess the needed variables and predictors of long LHS.
Fournier 坏疽的侵袭性以及相关的健康问题可能导致更复杂的临床病程,并可能导致住院时间延长。本研究旨在评估影响住院时间(LHS)的因素及其与 Fournier 坏疽患者结局的关系。
对 2017 年至 2023 年在沙特阿拉伯阿卜杜勒阿齐兹国王大学医院(KAUH)诊断为 Fournier 坏疽的患者进行回顾性研究。收集患者的住院时间(LHS)、年龄、BMI、临床和手术数据以及结局等资料。
研究对象的平均年龄为 59.23±11.19 岁,平均 BMI 为 26.69±7.99kg/m,症状持续时间平均为 10.27±9.16 天。最常见的首发症状为肿胀或硬结(64%),88%合并有糖尿病(DM)(84%),且 76%的 DM 控制不佳。24%的患者存在混合微生物感染,其中大肠杆菌最常见(52%)。平均住院时间(LHS)为 54.56±54.57 天,24%的患者 LHS 超过 50 天。较长的 LHS(>50 天)与未接受合适初始抗生素治疗的患者有关,而较短的 LHS 与接受亚胺培南或万古霉素和美罗培南联合治疗替代抗生素后不耐药的患者有关。重建患者的 LHS 明显较长,平均体温较高。然而,多元回归分析未发现研究变量可预测较长的 LHS。
了解预测 LHS 的因素有助于实施以患者为中心的治疗,并可能有助于预测高危患者需要更激进的治疗或额外的治疗。需要进行未来更大样本量的多中心前瞻性研究,以评估所需的变量和预测长 LHS 的因素。